Skip to content

Clinical trials

Endocrine System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Clear all

322 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20021
20041
20054
20062
20074
20086
20097
20106
201110
201212
201316
201419
201512
201612
201713
201820
201914
202020
202124
202215
202318
202414
202515
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed184
Unknown status50
Recruiting33
Terminated20
Active, not recruiting16
Not yet recruiting9
Withdrawn7
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)26
Eli Lilly and Company13
University of Pittsburgh8
AstraZeneca7
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)6
Pfizer6
Merck Sharp & Dohme LLC5
University Hospital, Basel, Switzerland5
Ascendis Pharma Endocrinology Division A/S4
M.D. Anderson Cancer Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases322
Metabolic Diseases104
Diabetes Mellitus100
Glucose Metabolism Disorders98
Diabetes Mellitus, Type 267
Diabetes Mellitus, Type 135
Rare Diseases34
Autoimmune Diseases33
Neoplasms23
Obesity23

Trials

Showing 26 to 50 of 322. Each trial links to its page on Pharma Observatory.

222 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.